Ventilator-Associated Pneumoni A Literature Review

To encourage physicians, ICU nurses, and respiratory therapist to use the ventilator associated pneumonia bundle in all ventilated patients in an intensive care unit.

It has been repeatedly stated that oral care is important in the prevention of ventilator-associated pneumonia (VAP). Endotracheal intubation predisposes patients to developing VAP. The tube acts as a conduit from the mouth to the lungs – a perfect track for bacteria to descend upon. Khezeri, et al. (2014) suggest that “the presence of an endotracheal tube (ETT) inhibits normal coughing, normal swallowing, and the protection of the trachea contact by epiglottis closure.” In addition, an endotracheal tube keeps the patients mouth open – leading to dryness. Bacteria are not washed away by saliva. Also, Landgraf, et al. (2017) mention that the presence of an endotracheal tube in the mouth causes “changes in the oral epithelium” which “might indicate risk for infection in intensive care patients

Ventilator-associated pneumonia is a bacterial infection that occurs in the lower respiratory system within the first 48 hours of endotrachal intubation (Lewis, Dirksen, Heitkemper, Bucher, & Camera, 2011). Although any hospital patient is susceptible to pneumonia, ventilator dependent patients are at the highest risk of acquiring pneumonia. The purpose of this paper is to identify the risk factors, incidences, and preventions of ventilator-associated pneumonia (VAP) using a quantitative research study performed in Malaysia. “The aim of this

Ventilator Associated Pneumonia (VAP) is the second most common infection that patients develop while in the hospital and the leading cause of death due to hospital acquired infections (Augustyn, 2007). Hospital acquired infections are also known as nosocomial infections. VAP usually happens when patients are on mechanical ventilation (the ventilator) for over 48 hours. VAP is costly because it increases the hospital length of stay, often times in the Intensive Care Units (ICU). Patients are often on the ventilator and are receiving antibiotics to treat the pneumonia. This paper will show that

The purpose of this document is a critical study and analysis of the oral care provided by nursing staff as part of the Ventilator Care Bundle (VCB) and to assess whether the frequency of mouth care performed is related to the prevention of Ventilator Associated Pneumonia (VAP) in patients mechanically ventilated (Zilberberg et al. 2009).

I currently work as a professional health care provider on a team of clinicians at an intensive care unit (ICU). One of the most commonly seen problems that we have to deal with an attempt to prevent is Ventilator-Associated Pneumonia (VAP). VAP is one of the most widespread hospital acquired infections and generally transpires two day post-mechanical ventilation, generally as a consequence of microorganisms infiltrating the lower end of the respiratory tract and the lung parenchyma often via an endotracheal tube or tracheostomy (Amanullah, 2011).

The study subjects were gathered from various ICU centers at various institutions, which is appropriate for study given the study objective and what the study was aiming to examine and determine (using a study drug vs. placebo in an ICU environment). Inclusion criteria were appropriate to assess the effects of the anti-pyretic acetaminophen due to their specificity of including those patients who were febrile with an infection that had been initiated with antimicrobial therapy. The exclusion criteria was extensive and included patient characteristics and disease states that may have skewed the true effect of acetaminophen. It was appropriate to limit these patients with the exclusion criteria from receiving treatment since their comorbidities

In clinical experience, it is seen that many patients in the Intensive Care Unit (ICU) are on mechanical ventilation. These patients range from having head trauma, heart surgery and respiratory problems yet there is no clear, concise systematic standard oral care procedures noted on the different floors in the hospital. Oral care is a basic nursing care activity that can provide relief, comfort and prevention of microbial growth yet is given low priority when compared to other critical practices in critically ill patients. The Center for Disease Control reveals that Ventilator-Associated Pneumonia (VAP) is the second most common nosocomial infection that affects approximately 27% of critically ill patients (Koeman, Van der Ven & Hak,

The mouth care protocol we use in our ICU includes suction toothbrushes, catheter kits, chlorhexidinegluconate oral rinse, suction swabs treated with Dentrifice, Biotene Moutwash and Bioene Oralbalance Gel Mouth Moisturizer . These interventions in addition to the strategies addressed at Memorial Hermann Hospital have been our practice at the VA. Because of this use of best practice and the competency of our ICU staff we have had a VAPS rate of 0 since the fall of 2014 (U.S. Department of Veteran Affairs,

The purpose of this paper is to assess the effects of oral care on ventilator-associated pneumonia for inpatient

Ventilator associated pneumonia (VAP) is a hospital acquired infection occurs in the intensive care unit (ICU) for the patients who are on mechanical ventilator. It further complicates the hospital course by extending the length of stay, increase the cost of treatment, and increases the mortality rate. It is estimated that about 1% to 3% patients on mechanical ventilator develops VAP per day. Compared to the previous years, the Chlorhexidine mouth care and other ventilator bundle strategies decreased the VAP rate. Evidence based research studies proved that almost 89.7% reduction in VAP occurs after the implementation of ventilator bundle and other care related to it (Hutchins et al,

Among critically-ill patients in acute care facilities, pneumonia is one of the most frequently acquired hospital infections (Curtin, 2011). Ventilator-associated pneumonia (VAP) is the second most common healthcare-associated infection (HAI) in the United States and it is responsible for approximately 25% of infections that occur in intensive care units (Sedwick et al., 2012). VAP is defined as a hospital-acquired lung infection that develops in patients who are intubated and receiving mechanical ventilation at the time of or within 48 hours prior to the onset of infection (Sedwick et al., 2012; Gianakis et al., 2015). The definition of VAP, provided by the Centers for Disease Control and Prevention (CDC), encompasses a combination of radiological,

The Ganz et al. (2009) research was performed in order to evaluate the ICU nurses oral care routines and if they were using appropriate, up-to-date evidenced based techniques and lastly if evidence-based practices (EBP) was associated with personal demographics and professional characteristics. Ganz et al. (2009) had found that previous research and studies has shown that poor oral hygiene may contribute to greater risks for pneumonia which results in an increase in mortality and morbidity (Ganz et al., p 133). In fact some of the research studies had stated that there was no documentation of the nurses oral care practices and these practices were not even up-to-date with recent evidence (Ganz et al., p 133). In addition to that, ventilator-associated

For this reason, further research should be studied on non-critical care floors to see if the same effectiveness of chlorhexidine is found.

Ventilator-associated pneumonia (VAP) is a hospital-acquired condition that is currently not on the Centers for Medicare and Medicaid Services’ (CMS) list of non-payment hospital-acquired infections (CMS, 2015). However, the thought of adding VAP to the list occurred in past discussion by CMS (CMS, 2008). This may change when there is an improved definition with clearer inclusion criteria that is currently being constructed by the CDC (Klompas et al., 2014). Nonetheless, the goal is to prevent hospital-acquired illnesses, such as VAP. After performing a review of care interventions for the prevention of VAP, a collaborative team between the Society for Healthcare Epidemiology of America, the Infectious Diseases Society of America, the American Hospital Association, the